Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,270,122
-$266,977 QoQ
Shares Held
52,746
-3.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,181
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 7%
None 93%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ameritas Investment Partners, Inc. holds $69,204,293 across 9 Drug Manufacturers - General names. PFE ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,973 | $20,357,926 | |
| 2 | ABBV |
AbbVie Inc.
|
49,206 | $12,382,197 | |
| 3 | AMGN |
Amgen Inc
|
25,196 | $9,123,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,130 | $8,369,204 | |
| 5 | JNJ |
Johnson & Johnson
|
28,599 | $7,263,286 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
55,741 | $7,042,317 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
54,193 | $3,122,599 | |
| 8 | PFE |
Pfizer Inc
This page
|
52,746 | $1,270,122 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,270,122 | 52,746 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,537,099 | 54,740 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $1,368,279 | 54,951 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $1,415,388 | 55,549 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $1,373,195 | 56,650 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $1,442,833 | 56,939 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $1,573,520 | 59,311 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $1,778,044 | 61,439 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,808,850 | 64,648 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $1,832,332 | 66,030 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $1,947,297 | 67,638 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $2,335,465 | 70,409 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $2,649,138 | 72,223 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $2,982,275 | 73,095 | Shares | Other | 2023-05-10 | |
| 2022-12-31 | $3,727,606 | 72,748 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $3,227,343 | 73,751 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $3,903,307 | 74,448 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $3,974,486 | 76,772 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $4,642,510 | 78,620 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $3,559,850 | 82,768 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $3,046,138 | 77,787 | Shares | Other | 2021-08-06 | |
| 2021-03-31 | $2,844,090 | 78,501 | Shares | Other | 2021-05-14 | |
| 2020-12-31 | $3,040,210 | 82,592 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $3,243,982 | 88,392 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,022,921 | 92,444 | Shares | Other | 2020-08-05 | |
| 2020-03-31 | $3,073,900 | 94,176 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||